The global IVD instruments market is expected to grow at a steady rate during the forecast period. The factors like increasing older population, rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the rise in diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities and launches are expected to positively influence the market growth over the next few years.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Immunochemistry

Clinical microbiology

POCT

SMBG

Tissue diagnostics

Molecular diagnostics

Hematology

Hemostasis

PART 07: Market segmentation by end-user

Hospitals and diagnostic laboratories

Home care

Academic and research institutes

PART 08: Geographical segmentation

IVD instruments market in Americas

IVD instruments market in EMEA

IVD instruments market in APAC

PART 09: Focus on emerging markets

PART 10: Market drivers

Strategic initiatives by vendors

Demand for personalized medicine

Growing focus on diagnosing life-threatening conditions

boosting POCT segment

High demand for automation and integration of multiple

processes driving new product development

PART 11: Impact of drivers

PART 12: Market challenges

Strained laboratory budgets and lowering reimbursement

affecting instrument sales

Industry consolidation posing threat to new entrants

Reduction in profits of manufacturers due to the US

medical device tax policies

Limitations of closed systems in IVD testing

PART 13: Impact of drivers and challenges

PART 14: Market trends

Potential opportunities for physician office laboratories

(POL)

Leasing of IVD instruments

Increase in M&A

Advances in technology

PART 15: Vendor landscape

Competitive scenario

PART 16: Key vendor analysis

Abbott Laboratories

Danaher

Roche Diagnostics

Siemens Healthcare

Thermo Fisher Scientific

Key companies to watch

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio